Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.

Lorusso, Vito; Crucitta, Enrico; Silvestris, Nicola; Rosati, G; Manzione, L; De Lena, M; Palmeri, S; Gebbia, V; Mancarella, S; Sobrero, A; Pezzella, G; Comella, P; Mangiameli, A; Muci, D

Lorusso, Vito; Crucitta, Enrico; Silvestris, Nicola; Rosati, G; Manzione, L; De Lena, M; Palmeri, S; Gebbia, V; Mancarella, S; Sobrero, A; Pezzella, G; Comella, P; Mangiameli, A; Muci, D.

Affiliation

Lorusso V; Operative Unit of Medical Oncology, Oncology Institute of Bari, Via Amendola 209, Bari 70126, Italy.

Oncol Rep ; 13(2): 283-7, 2005 Feb.

Article in En | MEDLINE | ID: mdl-15643512

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols / Urothelium / Deoxycytidine / Kidney Neoplasms Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2005 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links